Joseph S. Mohr
Keine laufenden Positionen mehr
Profil
Joseph S.
Mohr is the founder of Locust Walk Partners LLC (founded in 2008) and Locust Walk Securities LLC (founded in 2011) where he held no specific title.
Mr. Mohr is also the founder of Gloucester Pharmaceuticals, Inc. Mr. Mohr's former jobs include Principal at Schering-Plough Corp., Chief Business Officer at Azelon Pharmaceuticals, Inc., President & Chief Business Officer at Variagenics, Inc., and Executive Vice President at EMD Serono, Inc. Mr. Mohr's education includes an MBA from the University of Pennsylvania and an undergraduate degree from Vanderbilt University.
Ehemalige bekannte Positionen von Joseph S. Mohr
| Unternehmen | Position | Ende |
|---|---|---|
Gloucester Pharmaceuticals, Inc.
 Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gloucester Pharmaceuticals, Inc. develops products for the treatment of cancer patients. Its programs include cutaneous T-cell lymphoma (CTCL), peripheral T-cell lymphoma (PTCL), and multiple myeloma. The company was founded in May 2003 and is headquartered in Cambridge, MA | Gründer | 26.04.2011 |
Locust Walk Securities LLC
 Locust Walk Securities LLC Investment Banks/BrokersFinance Locust Walk Securities LLC is a securities brokerage firm headquartered in Boston, Massachusetts. The firm was founded by Geoffrey Meyerson and Joseph Mohr in 2011 and they are a subsidiary of Locust Walk Partners LLC. Locust Walk Securities serves as the broker-dealer for all Locust Walk engagements – enabling them to execute a wider range of securities-related transactions for their clients, which includes mergers and acquisitions, private placements and mezzanine financings, and partnerships involving equity investments. | Gründer | - |
Locust Walk Partners LLC
 Locust Walk Partners LLC Miscellaneous Commercial ServicesCommercial Services Locust Walk Partners LLC provides commercial supporting and advisory services. The firm involves in securities-related transactions for clients, including mergers and acquisitions, private placements & mezzanine financings and partnerships involving equity investments. The company was founded by Geoff Meyerson and Joseph Mohr in 2008 and is headquartered in Boston, MA. | Gründer | - |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | - |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | - |
Ausbildung von Joseph S. Mohr
| University of Pennsylvania | Masters Business Admin |
| Vanderbilt University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
Azelon Pharmaceuticals, Inc.
 Azelon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azelon Pharmaceuticals, Inc. develops biopharmaceutical drugs for the treatment of osteoporosis. It develops parathyroid hormone analogs for the treatment of bone diseases, which are characterized by deficits in bone formation, including osteoporosis, orthopedic conditions and renal bone disease. The company was founded by Paul Morley and Godfrey Marchand in 2000 and is headquartered in West Conshohocken, PA. | Health Technology |
Gloucester Pharmaceuticals, Inc.
Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gloucester Pharmaceuticals, Inc. develops products for the treatment of cancer patients. Its programs include cutaneous T-cell lymphoma (CTCL), peripheral T-cell lymphoma (PTCL), and multiple myeloma. The company was founded in May 2003 and is headquartered in Cambridge, MA | Health Technology |
Variagenics, Inc.
 Variagenics, Inc. Miscellaneous Commercial ServicesCommercial Services Variagenics, Inc. develops molecular diagnostic tests by identifying genetic markers associated with response to cancer therapies, with the goal of optimizing patient care through both biopharmaceutical collaborations and its own internal research programs | Commercial Services |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Locust Walk Partners LLC
Locust Walk Partners LLC Miscellaneous Commercial ServicesCommercial Services Locust Walk Partners LLC provides commercial supporting and advisory services. The firm involves in securities-related transactions for clients, including mergers and acquisitions, private placements & mezzanine financings and partnerships involving equity investments. The company was founded by Geoff Meyerson and Joseph Mohr in 2008 and is headquartered in Boston, MA. | Commercial Services |
Locust Walk Securities LLC
Locust Walk Securities LLC Investment Banks/BrokersFinance Locust Walk Securities LLC is a securities brokerage firm headquartered in Boston, Massachusetts. The firm was founded by Geoffrey Meyerson and Joseph Mohr in 2011 and they are a subsidiary of Locust Walk Partners LLC. Locust Walk Securities serves as the broker-dealer for all Locust Walk engagements – enabling them to execute a wider range of securities-related transactions for their clients, which includes mergers and acquisitions, private placements and mezzanine financings, and partnerships involving equity investments. | Finance |